Difficulty: Medium
Average Score: 68%
Practice
Heparin, an anticoagulant and naturally occurring glycosaminoglycan, exerts its pharmacological effects on the clotting cascade by activating antithrombin, thus indirectly inactivating both
Correct answer
A
Rationale
The correct answer is A) thrombin and factor Xa.
Heparin works by activating antithrombin, which in turn inhibits thrombin and factor Xa in the clotting cascade. Thrombin is a key enzyme in the coagulation pathway that converts fibrinogen to fibrin, leading to clot formation. Factor Xa is another important enzyme in the coagulation cascade that plays a role in converting prothrombin to thrombin.
Option B) prothrombin and factor X is incorrect because heparin does not directly inhibit prothrombin; it indirectly inhibits prothrombin by inactivating factor Xa, which then leads to decreased conversion of prothrombin to thrombin.
Option C) von Willebrand factor and factor IX is incorrect because heparin does not target these factors in the clotting cascade. Von Willebrand factor is involved in platelet adhesion and factor IX is part of the intrinsic pathway of coagulation, neither of which are directly affected by heparin.
Option D) Tissue factor and factor XIa is incorrect as heparin does not directly inhibit tissue factor or factor XIa. Tissue factor is involved in the extrinsic pathway of coagulation and factor XIa is part of the intrinsic pathway, neither of which are the targets of heparin.
Understanding how heparin works in the clotting cascade is crucial in the field of safety pharmacology, especially when considering its clinical applications in preventing and treating thrombotic disorders across different age groups. This knowledge is essential for healthcare professionals to ensure safe and effective use of anticoagulant medications in patients of all ages.
Heparin works by activating antithrombin, which in turn inhibits thrombin and factor Xa in the clotting cascade. Thrombin is a key enzyme in the coagulation pathway that converts fibrinogen to fibrin, leading to clot formation. Factor Xa is another important enzyme in the coagulation cascade that plays a role in converting prothrombin to thrombin.
Option B) prothrombin and factor X is incorrect because heparin does not directly inhibit prothrombin; it indirectly inhibits prothrombin by inactivating factor Xa, which then leads to decreased conversion of prothrombin to thrombin.
Option C) von Willebrand factor and factor IX is incorrect because heparin does not target these factors in the clotting cascade. Von Willebrand factor is involved in platelet adhesion and factor IX is part of the intrinsic pathway of coagulation, neither of which are directly affected by heparin.
Option D) Tissue factor and factor XIa is incorrect as heparin does not directly inhibit tissue factor or factor XIa. Tissue factor is involved in the extrinsic pathway of coagulation and factor XIa is part of the intrinsic pathway, neither of which are the targets of heparin.
Understanding how heparin works in the clotting cascade is crucial in the field of safety pharmacology, especially when considering its clinical applications in preventing and treating thrombotic disorders across different age groups. This knowledge is essential for healthcare professionals to ensure safe and effective use of anticoagulant medications in patients of all ages.